|
| 38091977 | An inflammation resolution-promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction. | Cardiovasc Res | 2024 |
| 37634147 | New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. | Eur Heart J | 2024 |
| 37831139 | Combination of computed tomography angiography with coronary artery calcium score for improved diagnosis of coronary artery disease: a collaborative meta-analysis of stable chest pain patients referred for invasive coronary angiography. | Eur Radiol | 2024 |
| 33509798 | Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone <i>et al</i>. | Ann Rheum Dis | 2023 |
| 37524628 | Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registry. | Arch Cardiovasc Dis | 2023 |
| 37647594 | Single Functional Group Platform for Multistimuli Responsivities: Tertiary Amine for CO<sub>2</sub>/pH/ROS-Triggered Cargo Release in Nanocarriers. | Biomacromolecules | 2023 |
| 37732835 | Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study. | Pharmacol Res Perspect | 2023 |
| 38035037 | Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn. | Eur Heart J Open | 2023 |
| 37568050 | CathAI: fully automated coronary angiography interpretation and stenosis estimation. | NPJ Digit Med | 2023 |
| 35576489 | Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection. | Cardiovasc Res | 2023 |
| 37054888 | Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial. | Am J Clin Nutr | 2023 |
| 37054880 | Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice. | Can J Cardiol | 2023 |
| 36943406 | Childhood maltreatment and leukocyte telomere length in men and women with chronic illness: an evaluation of moderating and mediating influences. | Psychol Med | 2023 |
| 36976640 | Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37307170 | Pharmacogenomic markers of metoprolol and α-OH-metoprolol concentrations: a genome-wide association study. | Pharmacogenomics | 2023 |
| 37401487 | Autoimmune Atrial Fibrillation. | Circulation | 2023 |
| 36720803 | A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation. | Mol Diagn Ther | 2023 |
| 36695071 | Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease. | J Cereb Blood Flow Metab | 2023 |
| 36546588 | Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. | Diabetes Obes Metab | 2023 |
| 36617264 | Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. | Eur J Prev Cardiol | 2023 |
| 36914033 | Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE Study. | Can J Cardiol | 2023 |
| 36778260 | Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy. | medRxiv | 2023 |
| 36610332 | Psychological distress, social support, and use of outpatient care among adult men and women with coronary artery disease or other non-cardiovascular chronic disease. | J Psychosom Res | 2023 |
| 36802845 | Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. | J Am Heart Assoc | 2023 |
| 36864560 | Females present higher dose-adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males. | Clin Transl Sci | 2023 |
| 36701426 | Study of effect modifiers of genetically predicted CETP reduction. | Genet Epidemiol | 2023 |
| 36564955 | Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. | ESC Heart Fail | 2023 |
| 36893776 | Inflammation contributes to cardiovascular risk in patients receiving statin therapy. | Lancet | 2023 |
| 36630964 | Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease. | Med | 2023 |
| 36410424 | Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans. | J Lipid Res | 2023 |
| 35953437 | Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking. | Eur Heart J Cardiovasc Pharmacother | 2023 |
| 36047604 | Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. | Alzheimers Dement | 2023 |
| 34587458 | Repurposing Colchicine for Heart Disease. | Annu Rev Pharmacol Toxicol | 2022 |
| 35383463 | Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes. | J Am Heart Assoc | 2022 |
| 35736394 | Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. | ESC Heart Fail | 2022 |
| 35474380 | ExPheWas: a platform for cis-Mendelian randomization and gene-based association scans. | Nucleic Acids Res | 2022 |
| 35439023 | Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophy. | Sci Signal | 2022 |
| 35377160 | Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT. | J Am Heart Assoc | 2022 |
| 35503402 | Trajectory of patients consulting the emergency department for high blood pressure values. | CJEM | 2022 |
| 35467114 | Correction to: Computed tomography angiography versus Agatston score for diagnosis of coronary artery disease in patients with stable chest pain: individual patient data meta-analysis of the international COME-CCT Consortium. | Eur Radiol | 2022 |
| 35762321 | Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. | Circulation | 2022 |
| 35856777 | Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. | Eur Heart J | 2022 |
| 35598801 | A New Era: Immunotherapy Applied to Contemporary Cardiovascular Practice. | Can J Cardiol | 2022 |
| 35817031 | Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study. | Diabetes Care | 2022 |
| 35716932 | Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies. | Int J Cardiol | 2022 |
| 35689378 | An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites. | Clin Transl Sci | 2022 |
| 35483753 | Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. | J Am Coll Cardiol | 2022 |
| 36776792 | Novel Humanized Biosimulator to Predict Coronary Obstruction in High-Risk Valve-in-Valve Procedures. | JACC Case Rep | 2022 |
| 36539718 | Evolution of burnout and psychological distress in healthcare workers during the COVID-19 pandemic: a 1-year observational study. | BMC Psychiatry | 2022 |
| 36414704 | Angiopoietin-like 2 is essential to aortic valve development in mice. | Commun Biol | 2022 |